WSJ What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure

Date: September 27, 2025
Host: Jack Pitcher

Episode Overview

This episode delivers a concise recap of the biggest movers in the stock market for the week, digging into the economic headlines and company news shaping investor sentiment. Jack Pitcher highlights record-setting stock indices, the ongoing AI-fueled economic optimism, standout wins for Intel, struggles for CarMax, and a major controversy affecting Tylenol's parent company, Kinview.

Key Discussion Points and Insights

1. U.S. Market Recap: Strong Economic Data, Sputtering Indices

• Indices Start Strong, End Soft:
  • All three major stock indexes set record highs on Monday but lost steam as the week progressed.
  • “Stocks opened hot this week when all three major indexes set records on Monday. But markets lost steam as the week went on…” (00:22)
• Economic Fundamentals Remain Solid:
  • Final GDP estimate for Q2 revised upward to 3.8% (from 3.3%).
  • Weekly jobless claims dropped; durable goods orders bounced back.
  • “All three data points back up the idea that the AI powered American economy is just fine and in fact is set to heat back up.” (00:39)
• Valuation Skepticism:
  • Concerns linger around pricey tech stocks and stress among lower income consumers.
  • “Skeptics point out the historically expensive valuations for top tech stocks and signs of stress among lower income consumers.” (00:53)
• Weekly Performance:
  • S&P 500: down 0.3%
  • Dow: down 0.1%
  • Nasdaq: down 0.7%

2. Intel’s Remarkable Rebound and Partnerships

• Major News and Surge:
  • Intel approaches Apple and TSMC for partnerships, per WSJ report.
  • Nvidia to invest $5 billion in Intel, deepening collaboration.
  • “The good times keep rolling for Intel... That came after last week's news that Nvidia will invest $5 billion in intel as part of a new partnership.” (01:16)
• Government Backing & Investor Reward:
  • U.S. government recently took a 10% stake in Intel, boosting confidence.
  • Since July’s decade-plus lows, Intel’s stock has nearly doubled.
  • “Patient investors have been rewarded. Since hitting decade plus lows as recently as July, Intel's stock has almost doubled.” (01:31)
• Performance Stats:
  • Shares up 20% this week and 46% for September; best run since 1987.

3. CarMax’s Earnings Miss and Sector Red Flags

• Massive Drop After Weak Quarter:
  • CarMax posted sharply lower sales and profits amid falling used car demand.
  • “CarMax, the biggest seller of used cars in the US posted dismal earnings on Thursday that sent its stock tanking.” (01:54)
• Industry-Wide Implications:
  • Q2 used car sales “crashing back to earth” after Q1 spike from tariff uncertainty.
  • CEO acknowledged ongoing consumer distress.
  • “CarMax's CEO told analysts the consumer has been distressed for a little while.” (02:07)
• Market Impact:
  • Shares fell 20% on Thursday; 23% for the week, hitting a five-year low.
  • Broader concern for the “real economy that isn’t benefiting from huge spending on AI.” (02:16)

4. Tylenol Under Fire: Kinview’s Legal Headache

• White House’s Stunning Statement:
  • President Trump advised pregnant women not to take Tylenol, citing alleged autism links—sparking medical community backlash.
  • “President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links.” (02:33)
• Litigation Fears Intensify:
  • Kinview bracing for a surge of new lawsuits.
  • Has previously fought off claims, with a key case dismissed in 2023 for lack of evidence.
  • “The drug maker has successfully fended off past lawsuits, including Most notably in 2023 when a federal judge ruled there wasn't sufficient evidence that Tylenol caused autism and dismissed lawsuits against Kinview.” (02:47)
• Stock Reaction:
  • Kinview shares lost over 10% this week; down 23% YTD.

Notable Quotes & Memorable Moments

• On robust economic signals:
  “All three data points back up the idea that the AI powered American economy is just fine and in fact is set to heat back up.” — Jack Pitcher (00:39)

• On Intel’s extraordinary rally:
  “Patient investors have been rewarded. Since hitting decade plus lows as recently as July, Intel's stock has almost doubled… Shares rose 20% this week and they're up 46% so far this month, on pace for their best performance since 1987.” — Jack Pitcher (01:31-01:38)

• On consumer struggles hitting CarMax:
  “CarMax's CEO told analysts the consumer has been distressed for a little while.” — Jack Pitcher (02:07)

• On the Tylenol controversy shaking the sector:
  “President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links.” — Jack Pitcher (02:33)

Timestamps for Key Segments

• Market Recap & Economic Data: 00:14–01:05
• Intel’s Surge & Partnerships: 01:10–01:45
• CarMax Earnings & Autos Sector: 01:54–02:22
• Tylenol, Kinview & Trump Statement: 02:26–02:59

Conclusion

Jack Pitcher’s wrap-up captures a market wrestling with both optimism and anxiety: ongoing records set to the tune of AI optimism, while fractures show up in traditional consumer sectors and healthcare. Investors basked in Intel’s resurgence, reeled from CarMax’s plunge, and braced for Tylenol’s looming legal storm. The episode provides a brisk, insightful rundown of the market’s pivotal events for the week.